Thank you, Russell and good morning everyone. We are pleased with our financial results for the fourth quarter and for the full year 2023, especially with the 23% year-over-year revenue growth during this industry downturn. As we entered 2024, the industry continues to deal with market weakness, but as Russell discussed, there are also clear signs of recovery and an expectation for a strong 2025. As a result of the current market conditions, we are guiding first quarter revenue of approximately $242 million with gross margins of around 43.5%, operating income of approximately $45 million and earnings per share of about $1.22. We expect full year 2024 revenue levels to be similar to 2023 with revenue weighted towards the second half of the year. Power is expected to remain solid throughout the year with the mature markets and memory recovering in the second half. Our strong systems backlog and the expected recovery of these markets sets us up to achieve our $1.3 billion revenue target in 2025. Looking at our fourth quarter, revenue and earnings per share finished above our revised guidance due to solid execution and continued demand for Purion, especially in the silicon carbide power market. Q4 revenue was $310.3 million, with system revenue at $241.8 million and CS&I at $68.5 million. Full year revenue was $1.13 billion, with systems revenue of $883.6 million and CS&I at $247 million. Q4 earnings per share of $2.15 was driven by higher than expected revenues and gross margin, as well as lower overall operating expenses. This performance led to full year earnings per share of $7.43. Despite softness in the general mature and memory markets, bookings and quoting activity for systems in the power segment remained solid and continued to support our revenue expectations. Bookings in the quarter were $236 million, maintaining our backlog at $1.2 billion, a portion of which stretches into 2025. Given the increase in installed Purion systems, we expect CS&I revenue to increase in 2024 over 2023. Although revenue will fluctuate quarter-to-quarter, CS&I should be modeled at approximately $260 million for 2024 and approximately $300 million for our $1.3 billion revenue model. Q4 gross margin finished at 44.4% and at 43.5% for the full year. In 2024 we expect to see year-over-year improvement in gross margin. However, quarterly gross margins will fluctuate based on product mix. We remain laser focused on margin improvement and have a number of initiatives underway to lower the cost of goods sold and to drive higher sales of Purion product extensions. Execution on these initiatives will allow us to model gross margin at greater than 45% in our $1.3 billion revenue model. Turning to operating expenses, the fourth quarter ended at 19% of revenue, better than our guidance, and at 19.9% of revenue for the full year. We expect OpEx in the first quarter of 2024 to be approximately 25% of revenue. The increase as a percentage of revenue is a result of the lower sales volume in the first quarter and the incremental investments we've made to support the higher revenue loads we anticipate in the future. OpEx as a percentage of sales is expected to decline over the course of 2024 given the higher volumes expected in the second half of the year. Investments in R&D will increase in 2024 to approximately 9.5% of revenue compared to the 8.6% of revenue we invested in 2023. The incremental funding of R&D will be focused on the continued development of our Purion product extensions and upgrades. As you would expect, we will continue to tightly manage spending while continuing to support the future growth of the business by solidifying our technology advantage in the specialty markets, increasing our footprint in the memory and advanced logic markets, and most importantly, continuing to invest in our employees and infrastructure to ensure we have the necessary skills, equipment and facilities required to achieve our financial models. Moving to our balance sheet and cash flow, we ended Q4 with $506.1 million of available cash and generated $65.6 million of cash from operations in the period and $156.9 million for the full year. We continued to execute against our share repurchase program, buying back $15 million of stock in the quarter. In total, we've returned over $185 million of cash to shareholders since 2019 through our share repurchase programs. Before turning the call over to Russell for final remarks, I wanted to remind you that we will be participating in a number of upcoming investor events, including Wolfe Research's Inaugural Semiconductor Conference in San Francisco on February 14 and Susquehanna's 12th Annual Technology Conference virtually on March 1. In addition, we intend to host a Capital Markets Day on July 11 of this year in San Francisco in the time slot we usually hold our technical symposium. At this event, we will provide our next long range financial model, discuss our expectations for the market, review our new product innovations, and introduce the team members that will help drive Axcelis towards its next phase of growth. We will provide more details on this event in the coming months, and we look forward to seeing many of you there. With that, I will now turn the call back to Russell for his closing comments.